Compare GVH & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GVH | VVOS |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 9.7M |
| IPO Year | 2023 | 2020 |
| Metric | GVH | VVOS |
|---|---|---|
| Price | $4.02 | $0.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $80.00 | $2.75 |
| AVG Volume (30 Days) | 16.2K | ★ 3.6M |
| Earning Date | 02-17-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,443,000.00 |
| Revenue This Year | $102,768.97 | $69.66 |
| Revenue Next Year | N/A | $48.38 |
| P/E Ratio | $0.74 | ★ N/A |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $0.03 | $0.55 |
| 52 Week High | $10.74 | $7.40 |
| Indicator | GVH | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 42.66 | 37.01 |
| Support Level | $1.03 | N/A |
| Resistance Level | $4.11 | $0.76 |
| Average True Range (ATR) | 0.34 | 0.14 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 2.00 | 1.10 |
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.